Becton Dickinson and Company (BDXB)

$48.16

up-down-arrow $0.66 (1.39%)

As on 31-May-2023 19:00EDT

Market cap

info icon

--

Revenue (TTM)

info icon

--

P/E Ratio

info icon

--

P/B Ratio

info icon

--

Div. Yield

info icon

--

Becton Dickinson and Company (BDXB) Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: -- High: --

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    --

  • ROEROE information

    --

  • ROCEROCE information

    --

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    --

  • Debt to EquityDebt to Equity information

    --

  • Book ValueBook Value information

    --

  • EPSEPS information

    --

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    --

10 Years Aggregate

CFO

$27,103.00 Mln

EBITDA

$36,860.00 Mln

Net Profit

$10,939.00 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Becton Dickinson and Company (BDXB)
-3.8 -4.7 -0.7 -6.1 15.3 -- --
BSE Sensex*
-11.7 -4.8 1.7 -7.5 3.9 5.1 9.9
As on 31-May-2023  |  *As on 09-Sep-2026
The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Becton Dickinson and Company (BDXB)

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical...  industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey. 

  • Pres, CEO & Chairman

    Mr. Thomas E. Polen Jr.

  • Exec. VP & CFO

    Mr. Christopher DelOrefice

  • Headquarters

    Franklin Lakes, NJ

  • Website

    https://www.bd.com

FAQs for Becton Dickinson and Company (BDXB)

The share price of Becton Dickinson and Company (BDXB) is $48.16 (NYSE) as of 31-May-2023 19:00 EDT. Becton Dickinson and Company (BDXB) has given a return of 15.28% in the last 3 years.




PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2022
7.59
0.53
2021
7.64
0.68
2020
18.13
0.67
2019
--
--
2018
--
--

The 52-week high and low of Becton Dickinson and Company (BDXB) are Rs -- and Rs -- as of 10-Sep-2026.

Becton Dickinson and Company (BDXB) has a market capitalisation of -- as on 31-May-2023. As per SEBI classification, it is a company.

Before investing in Becton Dickinson and Company (BDXB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.